NZP NEWS

US Patent Issued

New Zealand Pharmaceuticals Ltd is pleased to announce that the U.S. patent 8,410,063, entitled “N-acetyl mannosamine as a therapeutic agent” was issued on April 2, 2013. The invention relates to compositions and methods for treating kidney and muscle dysfunction that involves use of therapeutic amounts of N-acetyl mannosamine and relates to Intellectual Property exclusively licensed to NZP from the U.S. NHGRI.